Active Ingredients:
Hydroquinone USP, 4% (40 mg/g);
Octinoxate USP, 7.5%; Oxybenzone
USP, 5.5%
Inactive Ingredients:
Ascorbic acid, BHT, butylparaben, cetyl alcohol, disodium EDTA, glycerin, methylparaben, propylparaben, saponins, sodium lauryl sulfate, sodium metabisulfite, stearyl alcohol, tocopheryl acetate, water (aqua)
Lori Moreno
3 months agoThis light weight moisturizer has SPF for under my make up and also has the ingredient Hydroquinone which helps me keep my brown spits away!!
ashley meyer
1 years agoI love this sunfader! We go to florida frequently and it helps alot afterward or to avoid if using while there.
Jessica Bernhard
1 years agoMy skin has never looked better!
Brittnay Velasquez
1 years agoHelps with sundamage
Sommer Moore
2 years agoI like that it has sunscreen
Reanee Grab
3 years agoI was happy with this product.
Julie Williams
3 years agoThis makes skin looks good
Laura Mahoney
3 years agoGreat addition to my regimen.
Tia Wells
4 years agoThis was the added boost my Nuderm system needed.
Karla Mancilla
4 years agoI don’t know what I would do without Obagi’s Sunfader. It has completely removed all the acne spots and sun pigmentation I had. People always stop me and ask how I have such beautiful porcelain skin. I show them pictures and they can’t believe that was my skin before Obagi. Thank you Obagi!!!
ALex Curiel
4 years agoamazing 😍
Need to Know
Important Safety Information for Sunfader (contains 4% hydroquinone)
CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Important Safety Information for Sunfader (contains 4% hydroquinone)
CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Please see Prescribing Information for Sunfader
PRECAUTIONS (ALSO SEE WARNINGS): Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.
Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.
Important Safety Information for Sunfader (contains 4% hydroquinone)
CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS: Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
How to Use
- A thin application should be applied once or twice daily or as directed by a physician.
- Sun exposure should be limited by using a sunscreen agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening for reoccurring.
- Please see above for additional important safety information
- Store at controlled room temperature: 15°C–25°C (59°F–77°F)
- Keep out of direct sunlight
- A thin application should be applied once or twice daily or as directed by a physician.
- Sun exposure should be limited by using a sunscreen agent or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening for reoccurring.
- Please see above for additional important safety information
- Store at controlled room temperature: 15°C–25°C (59°F–77°F)
- Keep out of direct sunlight